MedTrace Logo

Ambu® Auragain™ as a Conduit for Intubation in Paediatrics

NCT03955094 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 16

Last updated 2020-08-05

No results posted yet for this study

Summary

This study will be conducted as a prospective observational study

This study will be done in any of the operating theatres of University Malaya Medical Centre

This study will involve paediatric cases ( ages 3-12 years )posted for elective operations which require general anaesthesia with endotracheal intubation

Ambu Aura Gain will be used as a conduit for intubation

Conditions

  • Pediatric Endotracheal Intubation

Interventions

DEVICE

Intubation via AMBU® AURAGAIN™

Success rate of paediatric intubation through AMBU® AURAGAIN™

Sponsors & Collaborators

  • University of Malaya

    lead OTHER

Principal Investigators

  • Ismiarti S Ina, MAnaes(UM) · University of Malaya

Study Design

Allocation
NA
Purpose
OTHER
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
3 Years
Max Age
12 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2019-11-01
Primary Completion
2020-04-30
Completion
2020-04-30

Countries

  • Malaysia

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03955094 on ClinicalTrials.gov